×
Is Molecular Remission the Goal When Treating Myeloma?
http://www.cancernetwork.com/ash-multiple-myeloma/molecular-remission-goal-when-treating-myeloma

Aug 12th, 2017 - As part of our coverage of the American Society of Hematology (ASH) Annual Meeting & Exposition, being held December 9–12 in Atlanta, we are speaking with Faith Davies, MD, about molecular remission in multiple myeloma. Dr. Davies is a professor of medicine and deputy director of the Myeloma Institute at the University of Arkansas for Medical Sciences in Little Rock. She is giving a talk titled...

Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
http://www.cancernetwork.com/ash-leukemia/management-philadelphia-chromosomepositive-acute-lymphoblastic-leukemia

May 12th, 2017 - As part of our coverage of the American Society of Hematology (ASH) Annual Meeting & Exposition held December 9–12 in Atlanta, we are speaking with Farhad Ravandi-Kashani, MD, professor of medicine and the chief of the section of developmental therapeutics in the department of leukemia at MD Anderson Cancer Center in Houston, about the management of patients with Philadelphia chromosome–positiv...

DLBCL Trials May Exclude Patients Who Need Novel Therapies Most
http://www.cancernetwork.com/ash-lymphoma/dlbcl-trials-may-exclude-patients-who-need-novel-therapies-most

Dec 12th, 2017 - In this interview we discuss how a short diagnosis-to-treatment interval in newly diagnosed diffuse large B-cell lymphoma is associated with worse outcomes and how this could lead to trials favoring patients with a longer diagnosis-to-treatment interval and better expected outcomes.

Treatment Strategies in Primary Mediastinal B-Cell Lymphoma
http://www.cancernetwork.com/ash-lymphoma/treatment-strategies-primary-mediastinal-b-cell-lymphoma

Jul 12th, 2017 - As part of our coverage of the American Society of Hematology (ASH) Annual Meeting & Exposition held December 9–12 in Atlanta, we are speaking with Kieron Dunleavy, MD, about the latest strategies to treat primary mediastinal B-cell lymphoma (PMBCL). Dr. Dunleavy is a professor of medicine and the director of the lymphoma program at George Washington University Cancer Center in Washington, DC. ...